Clinical Trials on Glabellar Crease
Total 10000 results
-
Hubei Cancer HospitalRecruiting
-
Regina Elena Cancer InstituteFondazione Policlinico Universitario Agostino Gemelli IRCCS; Catholic University... and other collaboratorsRecruiting
-
Ourotech, Inc.Barts & The London NHS Trust; Imperial College Healthcare NHS Trust; Hampshire... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast CancerUnited Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingTriple Negative Breast CancerUnited States
-
Vall d'Hebron Institute of OncologyRecruitingTriple Negative Breast CancerSpain
-
Fudan UniversityRecruitingBreast Cancer | Triple Negative Breast CancerChina
-
Grupo LusófonaFundação para a Ciência e a Tecnologia; Faculdade de Motricidade HumanaRecruitingBreast Cancer Female | Hormone-receptor-positive Breast CancerPortugal
-
Novartis PharmaceuticalsRecruitingEarly Breast CancerChina, United States, Canada, Germany, Taiwan, Israel, Portugal, Hong Kong, Argentina, Australia, India, South Korea, Brazil, Turkey (Türkiye), Mexico, Puerto Rico
-
Power Life Sciences Inc.Not yet recruitingBreast Cancer | Triple Negative Breast Cancer
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
University of Alabama at BirminghamRecruitingTriple Negative Breast CancerUnited States
-
Sun Yat-sen UniversityRecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
University of Illinois at ChicagoRecruitingTriple Negative Breast CancerUnited States
-
Shengjing HospitalRecruiting
-
European Institute of OncologyRecruitingTriple Negative Breast CancerItaly
-
Dr Rajendra A. BadweTata Memorial HospitalRecruitingHER2 Positive Breast Cancer | Carcinoma Breast Stage IIndia
-
Queen Mary University of LondonHoffmann-La Roche; MedSIR; Westdeutsche Studiengruppe GmbH (WSG)Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
MedSIRMerk Sharp & Dohme España S.A.Active, not recruitingBreast Cancer | Triple Negative Breast CancerSpain
-
NCIC Clinical Trials GroupCompleted
-
University of Wisconsin, MadisonCompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
University Hospital, LilleCompletedBreast Cancer | Breast Neoplasms | Breast Carcinoma | Breast TumorFrance
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
Institut Paoli-CalmettesMSD France; OncodistinctActive, not recruitingInflammatory Breast CancerFrance
-
Ourotech, Inc.Barts & The London NHS TrustTerminatedTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsUnited Kingdom
-
Sun Yat-sen UniversityCompletedTriple Negative Breast CancerChina
-
Assiut UniversityActive, not recruitingBreast Cancer | Breast Neoplasms | Safety of Breast Coservative Multicenteric Breast Cancer | MulticentricEgypt
-
Tata Memorial HospitalActive, not recruiting
-
Spanish Breast Cancer Research GroupFundación ADEYCompletedBreast Cancer, MaleSpain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Canadian Cancer Trials GroupActive, not recruitingStage II Breast Cancer | Stage IIIA Breast CancerUnited States, Canada, Puerto Rico
-
University of VirginiaCelldex TherapeuticsWithdrawn
-
Institute of Applied BiosciencesHellenic Cooperative Oncology GroupEnrolling by invitationTriple Negative Breast CancerGreece
-
Nova Scotia Health AuthorityObafemi Awolowo UniversityCompletedTriple Negative Breast CancerCanada
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsTerminatedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, China, Germany, Japan, Brazil, Mexico, Romania, Switzerland, Ukraine and more
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
Jeong Eon LeeAsan Medical Center; Seoul National University Hospital; Gangnam Severance Hospital and other collaboratorsActive, not recruiting
-
Fudan UniversityActive, not recruitingTA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA SignatureBreast Cancer | Triple Negative Breast CancerChina
-
NSABP Foundation IncNational Cancer Institute (NCI); Radiation Therapy Oncology GroupActive, not recruitingStage II Breast Cancer | Stage IB Breast CancerUnited States, Canada, Israel, Puerto Rico, Korea, Republic of, Japan, Ireland
-
A Bapsi Chakravarthy, MDCompletedResistant Breast Cancer | Non-metastatic Invasive Breast CancerUnited States
-
Baylor Research InstituteEli Lilly and CompanyCompletedTriple Negative Breast CancerUnited States
-
Joyce O'ShaughnessyTakedaCompletedTriple Negative Breast CancerUnited States
-
Indiana UniversityCompletedTriple Negative Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaTrans Tasman Radiation Oncology GroupCompleted
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedBreast Cancer | Triple Negative Breast CancerChina
-
NYU Langone HealthNational Institutes of Health (NIH)TerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
Roswell Park Cancer InstituteCompletedNode Negative Breast Cancer | Node Positive Breast Cancer
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuspended
-
Institut BergoniéCompletedPatients With Breast Cancer and Breast Surgery RequiringFrance